Multiple Sclerosis therapy (AnTolRx)

N/A

Report date: 2024/10/10 16:24:07

Base Information

Drug NameMultiple Sclerosis therapy (AnTolRx)
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnTolRx Inc
China Registration ClassN/A

Develop Information

Active CompaniesAnTolRx Inc
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A